Abstract
Whole slide imaging (WSI) of pathology glass slides with high-resolution scanners has enabled the large-scale application of artificial intelligence (AI) in pathology, to support the detection and diagnosis of disease, potentially increasing efficiency and accuracy in tissue diagnosis.
Despite the promise of AI, it has limitations. “Brittleness” or sensitivity to variation in inputs necessitates that large amounts of data are used for training. AI is often trained on data from different scanners but not usually by replicating the same slide across scanners. The utilisation of multiple WSI instruments to produce digital replicas of the same glass slides will make more comprehensive datasets and may improve the robustness and generalisability of AI algorithms as well as reduce the overall data requirements of AI training.
To this end, the National Pathology Imagine Cooperative (NPIC) has built the AI FORGE (Facilitating Opportunities for Robust Generalisable data Emulation), a unique multi-scanner facility embedded in a clinical site in the NHS to (a) compare scanner performance and (b) replicate digital pathology image datasets across WSI systems.
The NPIC AI FORGE currently comprises 15 scanners from 9 manufacturers. It can generate approximately 4000 WSI images per day (approximately 7Tb of image data). This paper describes the process followed to plan and build such a facility.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The NPIC AI FORGE is supported by a 50 million pounds investment from by the Data to Early Diagnosis and Precision Medicine strand of the governments Industrial Strategy Challenge Fund, managed and delivered by UK Research and Innovation. (UKRI - Project no. 104687).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Correspondence contact information updated
Data Availability Statement
Data within this study are available from the corresponding author, upon reasonable request.
